IDAAM Publications welcomes Original Research, Review, Mini-Reviews and Rapid Communications that precisely and concisely report on innovative works, meaningful developments and advances in Scientific, Technical and Medical (STM) field.

IDAAM pledges to publish work executed in compliance of ethical codes and conduct with no destructive experimentation unless required essentially and duly approved by relevant authorities aimed for total wellness and encouraging positive development in present and future society.

Author publishing results from in-vivo experiments involving animal or humans should state whether due permission for conduct of these experiments was obtained from the relevant authorities/Ethics committee/Institutional Review Board and copy of same should be attached with the submission.

Conflict of interest information for each author needs to be part of the manuscript. The ICMJE has developed a uniform conflict of interest disclosure form (http://www.icmje.org/downloads/coi_disclosure.pdf). The corresponding author has to complete this form and should be submit along with manuscript.

Authors are requested to read all the given instructions in this section and strictly abide by same in order to ensure quick and easy processing of manuscripts.

TYPES OF MANUSCRIPTS

Original Research Papers contain innovative, hypothesis-driven research that is supported by sound experimental design, methodology, and data interpretations. 

Reviews, usually by invitation and organized into themed issues, report on recent advances in pharmaceutical research.

Mini-Reviews discuss a more narrowly focused topic of recent research. Unsolicited reviews are considered only if they are authored by investigators who have demonstrated expertise in the relevant areas. 

Rapid Communications provide a venue for fast-breaking research updates or other news items. The justification for rapid communication should be stated in the cover letter during submission.

PREPARATION OF MANUSCRIPTS 

Manuscripts must be prepared in compliance with “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations)” developed by International Committee of Medical Journal Editors, December 2013 (http://www.icmje.org/recommendations).

Page layout:

The pages shall be numbered consequently starting with the title page and the article must be arranged in the following order:

Title page, Abstract, Introduction, Materials and Methods, Results, Discussion or Results and Discussion, Conclusion, Acknowledgements, References, Illustrations. All the references, figures and tables in the text shall be numbered in order of their occurrence in the article. The length of Research Papers should have at least 15 pages, Review Articles in the range of 15-30 pages and Rapid Communications are limited to 15 pages inclusive of illustrations.

Manuscripts should be written in clear and concise English, bearing in mind that English is not the native language of many readers. Terminologies that are not generally understood should be avoided; however if it is absolutely necessary to use such terms, they must be defined. No abbreviations on acronyms shall be used in the titles or Abstract acronyms except for measurements. No sentence shall start with a numeral. Abbreviations like “&” and “etc” shall be avoided in the paper. The entire MS word document with graphs and illustration pasted in it shall not exceed 2 MB.

Title Page

Title page should contain a specific and informative title of the paper in not more than 50 characters and name(s) of the author(s). Names of the authors should appear as initials followed by surnames for men (example: LJ Roberts) and one given-name followed by surname for women (example: Elizabeth Taylor). Full names may be given in some instances to avoid confusion. Names should not be prefixed or suffixed by titles or affiliation(s). The author to whom all correspondence be made should be denoted by an asterisk mark and his/her complete postal and valid email address must be mentioned at the bottom left corner. Trivial sub-titles such as ‘Title’, ‘Author’, ‘Address’ or ‘Place of Investigation’ shall not be included in the title page. Title page should be aligned centre except for “* Address For correspondence”.

Abstract 

Reviews, Mini Reviews, Original Research Articles, and Rapid Communications should require an abstract. The Abstract should start on a separate page not exceeding 250 words. For Research Articles, the abstract should include a brief (1 or 2 sentence) statement for each of the following sections: Introduction, Methods and Materials, Results and Discussion, and Conclusion written in paragraph form. All abstracts must be written in one paragraph, with no subheadings, equations, tables, reference citations or graphics.

Key-words 

Provide four to ten relevant key words at the end of abstract preferably from MeSH terms provided by National Library of Medicine.

Introduction 

The introduction should not be an extensive review of the literature but should refer only to previously executed work which has a direct bearing on the topic to be discussed.

Materials and methods

Materials and methods should be written clearly and in such detail that the work can be repeated by others. Procedural detail that has been published previously should be referred to by citation. When a modified procedure is used, only the author’s modifications of the previously published method need to be given in detail. The statistical method and the level of significance chosen shall be clearly stated, IDAAM encourage work that has been subjected to an appropriate statistical test at each level of significance. All required approvals issued by local authorities and/or concern governing bodies to ethically conduct the subject work must be acknowledged.

Results 

All findings presented in tabular or graphical form shall be described in this section. The data should be statistically analyzed and the level of significance be stated. Data that is not statistically significant need only to be mentioned in the text, no illustration is necessary. All Tables and figures must have a title or caption and a legend to make them self-explanatory.

Discussion 

The discussion should involve the significant findings presented. Wide digressions are unacceptable because of the limitations of space. Discussion can also be combined with Results under one section, as Results and Discussion.

Conclusion

In a separate section, the major findings of the study, social contribution/implications, future scope and usefulness of the study shall be summarized. This paragraph should address the hypothesis or purpose stated earlier in the paper.

Acknowledgments 

The source of any inspiration, motivation, financial support, gifts, technical assistance and advice received for the work being published must be indicated in the Acknowledgments section.

References 

Author(s) are responsible for the accuracy and completeness of their references as these will not be checked by the editorial office. IDAAM encourage authors to use references of competent and globally accessible sources. References should be numbered consecutively in the order in which they are previously mentioned in the text and not in alphabetic order. Identify references in text, tables, and legends by Arabic numerals in superscript in square brackets. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals.

The commonly cited types of references are shown here, for other types of references such as electronic media; newspaper items, etc. please refer to ICMJE Guidelines. (http://www.icmje.org).

Articles in Journals

Format: Author(s) (Surname Initials). Title of article. Name of Journal. Year; Volume (issue): page no.

Zhang YT, Shen LN, Wu ZH, Zhao JH, Feng NP. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 2014; 471(1-2): 449-52.

Wavikar PR1, Vavia PR. Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery. J Liposome Res. 2014; 9:1-9. 

(If more than six authors, the first six shall be listed followed by et al)

Books and Other Monographs 

Format: Author(s) of chapter (Surname Initials). Title of chapter. In: Editor(s) name, editors. Title of book, edition Number. Place of publication: Publisher; Year of publication. page numbers

Roberts LJ, Morrow JD. Analgeic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbart LE, Gilman AG, ed. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill; 2001. 687-732.

Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 182-184, 296-303, 311-312. 

Government publication/Corporate author 

Format: Indian Pharmacopoeia, Vol. 2, Govt. of India, Controller of Publications, New Delhi, 1996, A-100.

Patent 

Format: Inventor(s) of patent (Surname Initials). Place of work carried out. Title. Patent name and number. Year Month Date.

Pilgaonkar PS, Rustomjee MT, Gandhi AS, Kelkar AA, Bagde P, inventors; Rubicon Research Pvt. Ltd, assignee. Controlled release formulation. US Patent 20080248107. 2008 Oct 9.

Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1.

Website 
Format: Author/editor (Surname Initials). Title [online]. Year [cited year month day]. Available from: URL: World Wide Web page

Shreeraj HS, Mitesh JS, Jitendra RS. An Overview on Brain Targeting Drug Delivery System [online]. 2009 [cited 2009 Jan 6]. Available from URL: http://www.pharmainfo.net/reviews/overview-brain-targeting-drug-delivery-system

Illustrations 

Illustrations includes but not limited to pictures, designs, figures, images, graphics, diagrams, photographs and chemistry schemes. The number of illustrations should be limited to the requirements.

Graphs and bar charts should preferably be prepared using Microsoft Excel and submitted as Excel file and also graph pasted in Microsoft Word file.

Drawings of chemical structures should as far as possible be produced with the use of a drawing program such as ChemDraw.

Diagrams made with Indian ink on white drawing paper, cellophane sheet or tracing paper with hand written captions or titles will not be accepted.

Photographs and photomicrographs should be submitted as ‘JPEG/TIFF with the resolution of 600 dpi or more’ images.

Captions and legends for Figure and Table should be typed on a separate page with numerals corresponding to the Figure and Table.

Keys to symbols, abbreviations, arrows, numbers or letters used in the illustrations should not be written on the illustration itself but should be clearly explained in the legend.

Illustrations should be free of all identifying information relative to the subject and institution.

All illustrations should be referred to as figures and numbered in Arabic numerals (Fig. 1, 2, etc.)

Please note: Because of technical complications which can arise by converting colour figures to ‘grey scale’ (for the printed version should you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.

Tables 

Each table should have a brief explanatory heading and sufficient experimental detail (following the table body as a footnote) so as to be intelligible without reference to the text. Tables must not resemble the material either in text or illustrations. Short or abbreviated column headings should be used and, if necessary, explained in footnotes, and indicated as a, b, c, and so on. Statistical measures of variation, S.D., S.E., etc. should be identified. Tables should be numbered separately in Arabic numerals (Table 1, 2, etc.).

Symbols and abbreviations

Abbreviations should be of those well known in scientific literature. In vitro, in vivo, in situ, ex vivo, ad libitum, et al. and so on are two words each and should be written in italics. None of the above is a hyphenated word.

Words such as carrageenan-induced inflammation, paracetamol-induced hepatotoxicity, isoproterenol-induced myocardial necrosis, dose-dependent manner are all hyphenated.

The use of the International System of Units (SI) is recommended. For meter (m), gram (g), kilogram (kg), second (s), minute (m), hour (h), mole (mol), liter (l), milliliter (ml), microliter (μl). No pluralization of symbols is followed. There shall be one character spacing between number and symbol. A zero has to be used before a decimal. Decimal numbers shall be used instead of fractions.

Formulae and equations

Structural chemical formulas, process flow diagrams and complicated mathematical expressions should be very clearly presented. All subscripts, superscripts, Greek letters and unusual characters must be identified. Structural chemical formulas and process flow diagrams should be prepared in the same way as graphs.

COPYRIGHT GUIDELINES FOR AUTHORS 

Submission of a manuscript to IDAAM for publication implies that the same work has not been published, nor under consideration for publication or in press elsewhere, its publication is permitted by all authors and after accepted for publication it will not be submitted for publication anywhere else, in English or in any other language, without the written approval of the copyright-holder. It is compulsory for the authors to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who fail to adhere to this condition will be charged with all costs that IDAAM incurs and their papers will not be published.

All authors must sign the “Transfer of Copyright” agreement form and should be submitted along with manuscript.

SUBMISSION OF MANUSCRIPTS

Manuscripts will be subjected to peer review process to determine their suitability for publication provided they fulfill the requirements of the journal. After the review, manuscript will be returned for revision along with reviewer’s and /or editor’s comments. One original copy of the final revised manuscript should be submitted for publication within one month receiving the comments. 

Authors are strongly encouraged to send their manuscript through online submission management. An online submission service via Internet facilitates a speedy and cost-effective submission of manuscripts. Manuscripts should be submitted online to http://www.idaampublications.com. This web-based manuscript management system offers easy submission procedures. Authors are required to prepare separate files for Manuscript, Tables and Figures. 

CORRECTING PROOFS AND REPRINTS

A PDF/MS Word file of proof will be sent to the corresponding author as an e-mail attachment. Authors will be asked to check any typographical or minor clerical errors in the manuscript at this stage. No other major alteration in the manuscript is allowed. After publication authors can freely access the full text of the article as well as can download and print the PDF file.

IDAAM is keen to endeavor every possible effort to get the article corrected accurately and published in the earliest possible journal. Therefore, it is important to incorporate all the corrections and send back in ONE communication. Subsequent corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will be allowed. Proofs should be returned to IDAAM within 48 hours, otherwise manuscript will be published as it is and IDAAM will not entertain in any corrections/modifications thereafter. However if corresponding author finds any major correction(s) in published article, can informed to IDAAM, it will be acknowledged as erratum/errata in next issue. No gratis reprints will be provided as journal is made open access through URL http://www.idaampublications.in.

Article Processing Charges (APC)

IDAAM Publications publishes open access journals. Open access publishing intend towards the global exposure of author and all published articles without any hurdle. By ‘open access’ to the journals, we mean its free availability on the public internet, permitting each and every user to read, copy, download, print, distribute, search, or link to the full texts of these articles, or use them for any other rightful purpose by properly acknowledging and citing it, without financial, technical or legal barriers. It is a pathway for every interested reader to have an instant free access to the full text of all published articles. For more details see Article Processing Charges (APC) for individual journal.